104 related articles for article (PubMed ID: 12834841)
1. Impact of surface tension on the conversion rate of large to small surfactant aggregates.
Ruppert C; Pucker C; Markart P; Seibold K; Bagheri A; Grimminger F; Seeger W; Günther A
Biophys Chem; 2003 May; 104(1):229-38. PubMed ID: 12834841
[TBL] [Abstract][Full Text] [Related]
2. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of large-to-small surfactant aggregate conversion by serine protease inhibitors of the bis-benzamidine type.
Ruppert C; Pucker C; Markart P; Schmidt R; Grimminger F; Seeger W; Stürzebecher J; Günther A
Am J Respir Cell Mol Biol; 2003 Jan; 28(1):95-102. PubMed ID: 12495937
[TBL] [Abstract][Full Text] [Related]
4. Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates.
Veldhuizen RA; Inchley K; Hearn SA; Lewis JF; Possmayer F
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):141-7. PubMed ID: 8216208
[TBL] [Abstract][Full Text] [Related]
5. Respiratory support, surface activity and protein content during nosocomial infection in preterm neonates.
Griese M; Westerburg B; Potz C; Dietrich P
Biol Neonate; 1996; 70(5):271-9. PubMed ID: 8955913
[TBL] [Abstract][Full Text] [Related]
6. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary surfactant activity is impaired in lung transplant recipients.
Hohlfeld JM; Tiryaki E; Hamm H; Hoymann HG; Krug N; Haverich A; Fabel H
Am J Respir Crit Care Med; 1998 Sep; 158(3):706-12. PubMed ID: 9730994
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge.
Hohlfeld JM; Ahlf K; Enhorning G; Balke K; Erpenbeck VJ; Petschallies J; Hoymann HG; Fabel H; Krug N
Am J Respir Crit Care Med; 1999 Jun; 159(6):1803-9. PubMed ID: 10351922
[TBL] [Abstract][Full Text] [Related]
9. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
[TBL] [Abstract][Full Text] [Related]
10. Effects of surfactant subfractions on preterm rabbit lung function.
Yamada T; Ikegami M; Jobe AH
Pediatr Res; 1990 Jun; 27(6):592-8. PubMed ID: 2356104
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of surfactant protein B from canine surfactant large aggregates during formation of small surfactant aggregates by in vitro surface area cycling.
Inchley K; Cockshutt A; Veldhuizen R; Possmayer F
Biochim Biophys Acta; 1999 Aug; 1440(1):49-58. PubMed ID: 10477824
[TBL] [Abstract][Full Text] [Related]
12. Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin.
Bernhard W; Haagsman HP; Tschernig T; Poets CF; Postle AD; van Eijk ME; von der Hardt H
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):41-50. PubMed ID: 9224208
[TBL] [Abstract][Full Text] [Related]
13. An examination of the different variables affecting surfactant aggregate conversion in vitro.
Veldhuizen RA; Yao LJ; Lewis JF
Exp Lung Res; 1999 Mar; 25(2):127-41. PubMed ID: 10188107
[TBL] [Abstract][Full Text] [Related]
14. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.
Günther A; Schmidt R; Nix F; Yabut-Perez M; Guth C; Rosseau S; Siebert C; Grimminger F; Morr H; Velcovsky HG; Seeger W
Eur Respir J; 1999 Sep; 14(3):565-73. PubMed ID: 10543276
[TBL] [Abstract][Full Text] [Related]
15. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.
Meyer KC; Sharma A; Brown R; Weatherly M; Moya FR; Lewandoski J; Zimmerman JJ
Chest; 2000 Jul; 118(1):164-74. PubMed ID: 10893374
[TBL] [Abstract][Full Text] [Related]
16. Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction.
Hite RD; Seeds MC; Bowton DL; Grier BL; Safta AM; Balkrishnan R; Waite BM; Bass DA
Am J Physiol Lung Cell Mol Physiol; 2005 Apr; 288(4):L610-7. PubMed ID: 15347567
[TBL] [Abstract][Full Text] [Related]
17. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties.
Günther A; Schmidt R; Harodt J; Schmehl T; Walmrath D; Ruppert C; Grimminger F; Seeger W
Eur Respir J; 2002 May; 19(5):797-804. PubMed ID: 12030716
[TBL] [Abstract][Full Text] [Related]
18. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.
Schmidt R; Meier U; Yabut-Perez M; Walmrath D; Grimminger F; Seeger W; Günther A
Am J Respir Crit Care Med; 2001 Jan; 163(1):95-100. PubMed ID: 11208632
[TBL] [Abstract][Full Text] [Related]
19. [Effect of bile acids on surface tension of bronchoalveolar lavage fluid in rabbits].
Wang F; Zhao C; Tian Y; Yin Y
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Oct; 34(10):1465-8. PubMed ID: 25345943
[TBL] [Abstract][Full Text] [Related]
20. Changes in subphase aggregates in rabbits injured by free fatty acid.
Hall SB; Hyde RW; Notter RH
Am J Respir Crit Care Med; 1994 May; 149(5):1099-106. PubMed ID: 8173747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
